Entity family
Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.
This funder is selected. Its supporting articles are shown below.
…roval and could be introduced into UK clinical practice pending NICE approval. This would require an assessment of eligibility and a…
…te of whom fourteen were still on cannabidiol as they fulfilled NICE criteria for continuing prescribing. Of these, 8 had a Vagus Ne…
…is a recognised treatment for dystonia and has been approved by NICE since 2006. The European Federation of Neurological Societies a…
… tumour referrals that present with a headache. We propose that NICE guidance may need further adaption, with stricter guidance to r…
… took regular clobazam before cannabidiol, 37 after, to satisfy NICE requirements for prescribing. Where not tolerated, minimal dose…
…d for 24 months. Eligible participants are aged 45–65, meet the National Institute for Health and Care Excellence (NICE) criteria for clinical knee OA and engage in a minimum we…
…ransition from children’s to adult services is well recognised (National Institute for Health and Care Excellence. Transition from children’s to adults’ services for young peopl…
…care should be considered throughout all phases of the illness (National Institute for Health and Care Excellence. Parkinson’s disease in adults. [NG71] NICE; 2017). Despite the…
…Background NICE advises an individualised approach to prescribing anticipatory …
…ommunicated to the patient’s GP. The NICE Quality Standard 144 (National Institute for Health and Care Excellence. Quality statement 3: Anticipatory prescribing. In: Care of dyi…
…ce (NICE) in 2020. These briefings serve as the trigger for the NICE Technology Assessment process. Data on the medicines’ submissio…